Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Synthomer down after profit warning, but long-term picture still strong

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Synthomer (SYNT) 287p
Loss to date: 13%
Original entry point: Buy at 330p, 12 September 2019
A profit warning from chemicals firm Synthomer (SYNT) has highlighted some of the pitfalls of investing in the sector and provided a reminder of the need for patience in investing.
In a trading update, Synthomer said the ‘growing weakness in the global economy has created a more challenging backdrop’ for the chemicals industry, resulting in a slower trading environment throughout the third quarter of its financial year.
Given the wide-ranging uses for their products, chemicals companies are more exposed than many other sectors to wider macroeconomic situations, for better or worse.
The decline in Synthomer’s share price reflects the direction of the global economy or at least where people feel it is heading.
But the long-term fundamentals for Synthomer remain the same. A deal to acquire US-based Omnova Solutions means the firm is on the cusp of global expansion as it tries to keep up with demand for its products.
According to Canaccord Genuity analyst Alex Brooks, Synthomer’s underlying earnings are also growing faster than its peers, with the business now dominated by highly profitable speciality units.
In addition, the firm is one of just three major players in two European and Asian rubber markets, sectors where profit stability is much better now than in the past, according to Brooks.
SHARES SAYS: The long-term fundamentals remain unchanged. Stick with the shares.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.
Our website uses cookies to give you a better browsing experience.
You can choose to accept all cookies, or control which we use by clicking 'Manage cookies'. To learn more, read our cookie policy.